Boston, MA -- (SBWIRE) -- 09/16/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (E2open Inc (NASDAQ:EOPN), Home Inns & Hotels Management Inc. (ADR) (NASDAQ:HMIN), EPAM Systems Inc (NYSE:EPAM), Dendreon Corporation(NASDAQ:DNDN)
E2open Inc (NASDAQ:EOPN) shares declined 2.99% to $22.05. The company will host a conference call to discuss its fiscal 2014 second quarter financial results for the period ended August 31, 2013 on October 10, 2013 at 2:00 P.M. Pacific Time (5:00 P.M. Eastern Time), following the release of the Company's quarterly financial results. The results will also be available online at E2open's website http://investor.e2open.com/.
Is EOPN A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Home Inns & Hotels Management Inc. (ADR) (NASDAQ:HMIN) shares dropped 2.75% and closed at $34.24 in the last trading session. The company on August 12 announced its unaudited financial results for the second quarter ended June 30, 2013. Total revenues were in line with guidance and increased 10.5% to RMB 1.60 billion (US$261.0 million). Net income attributable to ordinary shareholders increased 160.2% year over year to RMB 94.8 million (US$15.4 million). Adjusted net income attributable to ordinary shareholders (non-GAAP) increased 28.8% year over year to RMB 139.7 million (US$22.8 million).
Is HMIN A Good Buy After The Recent Price Movement? Find Out Here
EPAM Systems Inc (NYSE:EPAM) shares dropped 2.75% and closed at $33.24 in the last trading session. The company on Sept. 12 announced the launch of a joint Big Data Innovation Lab with VisiQuate, a company that delivers dynamic SaaS enterprise performance management and business analytics solutions. The innovation lab was created to experiment with Big Data opportunities, advanced predictive sciences and the detection of complex business outliers, exceptions and anomalies. Initially, the companies are targeting the Healthcare and Energy sectors.
How Should Investors Trade EPAM After The Recent Volatility? Get Free Report Here
Dendreon Corporation(NASDAQ:DNDN) shares declined 2.74% to $3.02. On Sept. 9 DNDN’s stock was rated new Buy by R.F. Lafferty with a price target of $8. Lafferty noted low expectations for Provenge, a drug analysts have strong conviction will have a place in treatment of prostate cancer. Lafferty thinks the company is positioned to turn profitable. Against this backdrop, analysts view risk/reward as positive.
Additionally, the company on August 8 reported results for the second quarter ended June 30, 2013. Net loss in the second quarter of 2013 was $68.8 million, or $0.45 per share, compared to a net loss of $96.1 million, or $0.65 per share for the same period in 2012.
How Should Investors Trade DNDN After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)